Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy

The article presents data on epidemiology, risk factors, mechanisms of development, clinical features of cognitive impairment in patients with type 2 diabetes mellitus. The literature data about the dependence of the incidence and severity of cognitive impairment on the type of hypoglycemic therapy...

Full description

Bibliographic Details
Main Author: N.V. Pashkovska
Format: Article
Language:English
Published: Publishing House Zaslavsky 2018-02-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:http://iej.zaslavsky.com.ua/article/view/127097
id doaj-e8a7db838ffa41f5b169e0e212a82a9f
record_format Article
spelling doaj-e8a7db838ffa41f5b169e0e212a82a9f2020-11-24T20:52:16ZengPublishing House ZaslavskyMìžnarodnij Endokrinologìčnij Žurnal2224-07212307-14272018-02-01141768510.22141/2224-0721.14.1.2018.127097127097Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapyN.V. Pashkovska0State Higher Education Institution of Ukraine “Bukovinian State Medical University”, Chernivtsi, UkraineThe article presents data on epidemiology, risk factors, mechanisms of development, clinical features of cognitive impairment in patients with type 2 diabetes mellitus. The literature data about the dependence of the incidence and severity of cognitive impairment on the type of hypoglycemic therapy are analyzed. As well as the results of clinical and experimental studies concerning the peculiarities of cognitive functions against the background of using various antidiabetic agents — meglitinides, biguanides, thiazolidinediones, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, sodium-dependent glucose cotransporter 2 inhibitors and insulin.http://iej.zaslavsky.com.ua/article/view/127097type 2 diabetes mellituscognitive impairmenthypoglycemic therapy
collection DOAJ
language English
format Article
sources DOAJ
author N.V. Pashkovska
spellingShingle N.V. Pashkovska
Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
Mìžnarodnij Endokrinologìčnij Žurnal
type 2 diabetes mellitus
cognitive impairment
hypoglycemic therapy
author_facet N.V. Pashkovska
author_sort N.V. Pashkovska
title Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
title_short Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
title_full Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
title_fullStr Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
title_full_unstemmed Cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
title_sort cognitive impairment in patients with type 2 diabetes mellitus: the role of hypoglycemic therapy
publisher Publishing House Zaslavsky
series Mìžnarodnij Endokrinologìčnij Žurnal
issn 2224-0721
2307-1427
publishDate 2018-02-01
description The article presents data on epidemiology, risk factors, mechanisms of development, clinical features of cognitive impairment in patients with type 2 diabetes mellitus. The literature data about the dependence of the incidence and severity of cognitive impairment on the type of hypoglycemic therapy are analyzed. As well as the results of clinical and experimental studies concerning the peculiarities of cognitive functions against the background of using various antidiabetic agents — meglitinides, biguanides, thiazolidinediones, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, sodium-dependent glucose cotransporter 2 inhibitors and insulin.
topic type 2 diabetes mellitus
cognitive impairment
hypoglycemic therapy
url http://iej.zaslavsky.com.ua/article/view/127097
work_keys_str_mv AT nvpashkovska cognitiveimpairmentinpatientswithtype2diabetesmellitustheroleofhypoglycemictherapy
_version_ 1716800276027932672